<DOC>
	<DOCNO>NCT02345473</DOCNO>
	<brief_summary>Very factor may identify prognostic patient bladder cancer undergo radical cystectomy . Recently , detection circulate tumor cell show promise anticipate likelyhood distant metastasis survival patient breast cancer , melanoma , prostate cancer malignancy . In present study test detection rate circulate tumor cell use PCR base methodology peripheral blood patient undergoing radical cystectomy , correlate result clinical outcome .</brief_summary>
	<brief_title>Detection Clinical Significance Circulating Cancer Cells Patient Undergoing Radical Cystectomy</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Prior trans urethral resection bladder ( TUR ) Histological confirmation transitional cell carcinoma ( TCC ) bladder ECOG Performance Status ≤ 2 WBC count ≥4,000/μL ; platelet count ≥150,000/μL ; creatinine ≤1.8 mg/dL ; AST , ALT , alkaline phosphatase ≤2X upper limit normal , normal total bilirubin recent ( within 6 week cystectomy ) total body CT imaging study exclude distant metastasis well upper urinary tract TCC Neoadjuvant chemotherapy ( either plan already perform ) Patients receive investigational medication Subjects suitable radical cystectomy Patients willing participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Bladder cancer</keyword>
	<keyword>Circulating cancer cell</keyword>
</DOC>